Miralgin (Paracetamol, Caffeine)

Paracetamol, the active ingredient in Miralgin, is an analgesic presented as an oral tablet for oral use. Combined with caffeine, it helps relieve headache, migraine, fever and mild to moderate pain in adults and adolescents. It belongs to the analgesic and antipyretic class and is available over the counter across the European Union.

GNH USA supplies Miralgin as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and providing the product to hospitals, pharmacies and clinics worldwide through regulated distribution channels.

Miralgin, containing paracetamol and caffeine, is used to manage pain and fever through inhibition of prostaglandin synthesis and central nervous system stimulation.

- Headache: reduces intensity and duration of tension‑type and mild migraine headaches. - Migraine: provides adjunctive relief when combined with caffeine for acute migraine attacks. - Fever: lowers elevated body temperature in febrile conditions. - Pain: alleviates mild to moderate musculoskeletal, dental and postoperative pain.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Stomach upset: occasional dyspepsia or abdominal pain. - Insomnia: difficulty falling or staying asleep. - Increased heart rate: mild tachycardia. - Restlessness: feeling of jitteriness. - Headache: paradoxical headache in some users.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Liver toxicity: elevated transaminases or hepatic failure with overdose. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood disorders: thrombocytopenia or neutropenia. - Cardiovascular events: hypertension or arrhythmia in susceptible individuals.

Before using Miralgin, consider the following precautions: - Assess liver function: avoid or adjust dose in severe hepatic impairment. - Limit alcohol intake: concurrent alcohol can increase hepatotoxic risk. - Use lowest effective dose: minimize exposure while achieving symptom control. - Avoid in children under 12 years: unless directed by a healthcare professional. - Consult healthcare professional in pregnancy: safety not fully established. - Store at ambient temperature: keep in the original pack, protect from moisture.

Miralgin may interact with other medicines as follows:

Major Interactions (Avoid): - Warfarin: increased risk of bleeding. - Carbamazepine: reduced analgesic efficacy of paracetamol. - Lithium: potential for increased lithium toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: enhanced hepatotoxicity risk. - Other CNS stimulants (e.g., pseudoephedrine): increased stimulant side effects. - Antiepileptic drugs (e.g., phenytoin): altered metabolism of caffeine.